Role of melatonin in mucosal gastroprotection against aspirin-induced gastric lesions in humans.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/20443220
Conclusion of this study
Plasma gastrin levels were raised in subjects given melatonin or tryptophan plus ASA, but not in those with ASA alone. We conclude that melatonin and its precursor tryptophan given orally significantly reduce gastric lesions induced by ASA possibly due to (a) direct gastroprotective action of exogenous melatonin or that generated from tryptophan and (b) gastrin released from the gastric mucosa by melatonin or tryptophan.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study